Literature DB >> 26592191

Acute kidney injury: Buffered crystalloids or saline in the ICU--a SPLIT decision.

Michael Joannidis1, Lui G Forni2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26592191     DOI： 10.1038/nrneph.2015.190

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality.

Authors:  John H Boyd; Jason Forbes; Taka-aki Nakada; Keith R Walley; James A Russell
Journal:  Crit Care Med       Date:  2011-02       Impact factor: 7.598

2.  Effects of acetate on energy metabolism and function in the isolated perfused rat heart.

Authors:  A D Jacob; N Elkins; O K Reiss; L Chan; J I Shapiro
Journal:  Kidney Int       Date:  1997-09       Impact factor: 10.612

3.  Crystalloid fluid therapy: is the balance tipping towards balanced solutions?

Authors:  Paul J Young; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

4.  Fluid resuscitation after an otherwise fatal hemorrhage: II. Colloid solutions.

Authors:  L W Traverso; S J Hollenbach; R B Bolin; M J Langford; L R DeGuzman
Journal:  J Trauma       Date:  1986-02

Review 5.  The history of 0.9% saline.

Authors:  Sherif Awad; Simon P Allison; Dileep N Lobo
Journal:  Clin Nutr       Date:  2008-03-03       Impact factor: 7.324

6.  Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial.

Authors:  Paul Young; Michael Bailey; Richard Beasley; Seton Henderson; Diane Mackle; Colin McArthur; Shay McGuinness; Jan Mehrtens; John Myburgh; Alex Psirides; Sumeet Reddy; Rinaldo Bellomo
Journal:  JAMA       Date:  2015-10-27       Impact factor: 56.272

7.  A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.

Authors:  Abeed H Chowdhury; Eleanor F Cox; Susan T Francis; Dileep N Lobo
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

8.  Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS.

Authors:  Andrew D Shaw; Karthik Raghunathan; Fred W Peyerl; Sibyl H Munson; Scott M Paluszkiewicz; Carol R Schermer
Journal:  Intensive Care Med       Date:  2014-10-08       Impact factor: 17.440

Review 9.  Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation.

Authors:  M L Krajewski; K Raghunathan; S M Paluszkiewicz; C R Schermer; A D Shaw
Journal:  Br J Surg       Date:  2014-10-30       Impact factor: 6.939

10.  Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis.

Authors:  Neha Rohatgi; Tine Kragh Nielsen; Sara Petersen Bjørn; Ivar Axelsson; Giuseppe Paglia; Bjørn Gunnar Voldborg; Bernhard O Palsson; Óttar Rolfsson
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240
  10 in total
  2 in total

1.  Saliva-Induced Clotting Captures Streptococci: Novel Roles for Coagulation and Fibrinolysis in Host Defense and Immune Evasion.

Authors:  Kristofer Wollein Waldetoft; Tirthankar Mohanty; Christofer Karlsson; Matthias Mörgelin; Inga-Maria Frick; Johan Malmström; Lars Björck
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.

Authors:  M Joannidis; W Druml; L G Forni; A B J Groeneveld; P M Honore; E Hoste; M Ostermann; H M Oudemans-van Straaten; M Schetz
Journal:  Intensive Care Med       Date:  2017-06-02       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.